NIDA-CTO-0001
Division
HEAL Study
Investigator(s)
Title
Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence
Short Description
The purpose of this study is to assess the efficacy and safety of reserpine for the treatment of cocaine dependence.
Release Date
Dec 04, 2014
Description
The primary objective of this study is to assess the efficacy of reserpine in reducing cocaine use in subjects with cocaine dependence (DSM-IV criteria). The hypothesis is that reserpine will increase the weekly mean proportion of cocaine non-use days over the treatment period when compared to placebo as determined by self-report of cocaine use confirmed with urine assays for BE.
Accessibility Notice
Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.